CRYSTAL STONE: Open Payments
NPI 1518328624 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,273 in 93 payments from 18 companies in 2025. Trend: 2023 $1,616 · 2024 $1,515 · 2025 $2,273
Food & beverage: $2,163Education: $109
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $480 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $438 |
| Teva Pharmaceuticals USA, Inc. | 10 | $369 |
| E.R. Squibb & Sons, L.L.C. | 8 | $236 |
| Otsuka America Pharmaceutical, Inc. | 8 | $145 |
| Alkermes, Inc. | 4 | $92 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Lundbeck LLC | 3 | $64 |
| Lilly USA, LLC | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 3 | $56 |
Products named: FANAPT, CAPLYTA, COBENFY, AUSTEDO XR, REXULTI, ARISTADA, ABILIFY ASIMTUFII, Auvelity.
Industry payments across IL — which companies pay providers there.
